Aptorum Group GAAP每股收益为-1.60美元

2026-08-22 05:10

Aptorum Group press release (NIKI): 1H GAAP EPS of -$1.60.
For the six months ended June 30, 2026, and 2025, net loss attributable to Niki BioSolutions, Inc. (excluding net loss attributable to non-controlling interests) was $1,326,004 and $441,780, respectively.
Net loss of $1,307,300, negative working capital of $2,475,418, and net operating cash outflow of $1,553,720 for the six months ended June 30, 2026.

More on Aptorum Group